Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
Around **5-8%** average weight loss (beyond placebo) over 1 year
Heart health benefits: Weight loss and blood sugar control can significantly improve your overall cardiovascular outlook
retail pharmacies from 2020 to 2023
Key Takeaways: Novo Nordisk's oral Wegovy approval marks a major milestone, boosting its stock and positioning it as a leader in obesity treatment with the first pill-based GLP-1 medication in the US
Messages and data rates may apply and message frequency will vary
US$ 20.44
US$ 29.67
US$ 26.14
US$ 23.44
US$ 29.76
US$ 29.04
US$ 29.30
US$ 27.23
